---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-25-000023"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:33:21.730959+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q2 adj EPS $1.81; raises FY25 adj EPS outlook to $6.30-6.40, cuts GAAP view on litigation charges

## Summary
- Q2 revenue $98.9B (+8.4% YoY); GAAP EPS $0.80 vs $1.41; adj EPS $1.81 vs $1.83.
- Recorded $833M litigation charges and $471M premium deficiency reserve in Medicare Advantage.
- FY25 GAAP EPS guidance lowered to $3.84-3.94 from $4.23-4.43; adj EPS raised to $6.30-6.40 from $6.00-6.20.
- Aetna MBR 89.9% vs 89.6% with premium deficiency impact; medical membership 26.7M down 358k sequentially.
- Agreed to acquire certain Rite Aid prescription files and stores; cash flow from operations guided to at least $7.5B.

## SEC filing metadata
- accession: 0000064803-25-000023
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480325000023/0000064803-25-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480325000023/cvs-20250731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-25-000023
- JSON: https://secwatch.observer/filing/0000064803-25-000023.json
- Plain text: https://secwatch.observer/filing/0000064803-25-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.